Dennis M. Lanfear - Dec 30, 2022 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
President & CEO, Director
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Dennis M. Lanfear
Stock symbol
CHRS
Transactions as of
Dec 30, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 05:44 PM
Previous filing
Jan 6, 2022
Next filing
Jan 6, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Gift $0 -4K -0.92% $0.00 433K Dec 30, 2022 By Trust F1
holding CHRS Common Stock 580K Dec 30, 2022 Direct F2
holding CHRS Common Stock 87K Dec 30, 2022 By LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
F2 Includes 86,250 restricted stock units.
F3 These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.